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Abstract
Background: The incidence of oropharyngeal cancer (OPC) has been rising, especially among
middle-aged men. While Human Papillomavirus (HPV) has been irrevocably implicated in the
pathogenesis of OPC, the current HPV immunization uptake rate remains low in the US. The aim
of our study was to evaluate the impact of increased HPV vaccination coverage on HPVassociated OPC incidence and costs.
Methods: A decision analytic Markov model was constructed. Separate analyses were conducted
for hypothetical cohorts of 9-year-old boys and girls. Two strategies were compared: 1) Status
quo (maintaining the current vaccination uptake rates); 2) Increasing HPV vaccination uptake
rates to the Healthy People 2020 target (80%) for both genders. Sensitivity analyses were
performed to determine the impact of model input uncertainties on results.
Results: Increasing HPV vaccination uptake rates to the Healthy People 2020 target would be
expected to prevent nearly 100,000 cases of OPC and save $544 million by saving more than
twice the amount for each dollar spent on vaccination over lifetime. Increased HPV vaccination
coverage would result in 8,290 QALY gains in the overall population, and it would be costsaving for males and cost-effective for females with an incremental cost-effectiveness ratio of
$42,365 per QALY gained for females.
Conclusion: Expanding HPV vaccination rates would likely provide a cost-effective way to
reduce the incidence of OPC in the US, particularly among males given their higher baseline risk
of OPC and lower vaccination levels compared to females. Furthermore, widespread vaccination
coverage would provide health benefits for other HPV-associated diseases.

